Methyluracil ointment 10%, 25g

For external use:

• sluggish wounds

• burns,

• bone fractures,

• photodermatitis,

• trophic ulcers,

• bedsores,

• deep wounds.

The dosage regimen is set individually, depending on the dosage form used. The frequency of dressing changes depends on the depth and area of ??the wound surface, the intensity of exudation and the presence of necrotic masses.

Methyluracil as an active substance 10 g and an ointment base (medical petroleum jelly, water lanolin) up to 100 g.

• Hypersensitivity to dioxomethyltetrahydropyrimidine;

• excessive granulation in the wound.

Clinical and pharmacological group: A drug that improves trophism and tissue regeneration, for external use

Pharmaco-therapeutic group: Tissue regeneration stimulant

pharmachologic effect

Immunostimulating agent. Promotes the normalization of nucleic acid metabolism, accelerates the processes of cellular regeneration in wounds, accelerates the growth and granulation maturation of tissue and epithelization (including in rapidly proliferating cells of the gastrointestinal mucosa), stimulates erythro- and leukopoiesis, cellular and humoral factors of immunity. Possesses anabolic activity, anti-inflammatory effect. When applied externally, it also has a photoprotective effect.

Side effect

Perhaps: allergic reactions, burning sensation at the site of application.

Application during pregnancy and lactation

If necessary, use during pregnancy and during breastfeeding should take into account the expected benefits of therapy for the mother and the possible risk to the fetus.

Application in children

Use in children under 3 years of age is contraindicated.

special instructions

Preparations containing dioxomethyltetrahydropyrimidine should be used strictly as indicated.

Drug interactions

When applied externally, it is compatible with applications of antibacterial and antiseptic agents.

The simultaneous use of GCS reduces the effectiveness of this agent for external and local application.